Mostrar el registro sencillo del ítem

dc.contributor.authorBande Rodriguez, Manuel Francisco 
dc.contributor.authorFernández Díaz, Daniel
dc.contributor.authorFernández Marta, Beatriz
dc.contributor.authorRodriguez-Vidal, Cristina
dc.contributor.authorLago-Baameiro, Nerea
dc.contributor.authorSilva Rodríguez, Paula
dc.contributor.authorPANIAGUA FERNANDEZ, LAURA 
dc.contributor.authorBlanco Teijeiro, María Jose 
dc.contributor.authorPardo Pérez, María 
dc.contributor.authorPiñeiro Ces, Antonio 
dc.date.accessioned2022-03-16T08:37:17Z
dc.date.available2022-03-16T08:37:17Z
dc.date.issued2020
dc.identifier.issn2072-6694
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/33053887es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16253
dc.description.abstractUveal melanoma (UM) is the most common primary intraocular tumor in adulthood. Approximately 50% of patients develop metastatic disease, which typically affects the liver and is usually fatal within one year. This type of cancer is heterogeneous in nature and is divided into two broad groups of tumors according to their susceptibility to develop metastasis. In the last decade, chromosomal abnormalities and the aberrant expression of several signaling pathways and oncogenes in uveal melanomas have been described. Recently, importance has been given to the association of the mentioned deregulation with the expression of non-coding RNAs (ncRNAs). Here, we review the different classes of ncRNAs-such as long non-coding RNAs (lncRNAs) and microRNAs (miRNAs)-and their contribution to the development of UM. Special attention is given to miRNAs and their regulatory role in physiopathology and their potential as biomarkers. As important agents in gene regulation, ncRNAs have a huge potential for opening up therapeutic pathways, predicting response to treatment, and anticipating patient outcome for UM.en
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleThe Role of Non-Coding RNAs in Uveal Melanomaen
dc.typeJournal Articlees
dc.authorsophosBande, Manuel;Fernandez-Diaz, Daniel;Fernandez-Marta, Beatriz;Rodriguez-Vidal, Cristina;Lago-Baameiro, Nerea;Silva-Rodríguez, Paula;Paniagua, Laura;Blanco-Teijeiro, María José;Pardo, María;Piñeiro, Antonio
dc.identifier.doi10.3390/cancers12102944
dc.identifier.pmid33053887
dc.identifier.sophos36085
dc.issue.number10es
dc.journal.titleCancers (Basel)es
dc.organizationServizo Galego de Saúde::Dirección Xeral de Asistencia Sanitaria::Fundación Pública Galega de Medicina Xenómicaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario de A Coruña::Oftalmoloxíaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Oftalmoloxíaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)es
dc.relation.publisherversionhttps://mdpi-res.com/d://attachment/cancers/cancers-12-02944/article://deploy/cancers-12-02944.pdfes
dc.rights.accessRightsopenAccess
dc.subject.keywordFPGMXes
dc.subject.keywordCHUACes
dc.subject.keywordCHUSes
dc.subject.keywordIDISes
dc.typefidesArtículo de Revisiónes
dc.typesophosArtículo de Revisiónes
dc.volume.number12es


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional